Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (111-120 of 222) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individualsStephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 6, 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patientsJohn D Ryan, Andrew E Armitage, Jeremy F Cobbold, et al.
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
Vaccines|June 27, 2024
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBVCharlotte Davis, Dave Singh, Katie Anderson, et al.
Gastroenterology|May 13, 2019
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirPeter A C Wing, Meleri Jones, Michelle Cheung, et al.
The Lancet Regional Health. Europe|December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyRachael A Evans, Sabada Dube, Yi Lu, et al.
Cell Reports|October 12, 2025
Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine designZhiqing Wang, Isla Humphreys, Jocelyn Quistrebert, et al.
Scientific Reports|May 10, 2019
Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)Anna L McNaughton, Hannah E Roberts, David Bonsall, et al.
The Lancet Regional Health. Europe|August 19, 2024
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747]Rachael A Evans, Sabada Dube, Yi Lu, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceJulia di Iulio, Angela Ciuffi, Karen Fitzmaurice, et al.
Pageof 23

Showing results (111-120 of 222) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individualsStephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 6, 2017
Hepatic iron is the major determinant of serum ferritin in NAFLD patientsJohn D Ryan, Andrew E Armitage, Jeremy F Cobbold, et al.
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
Vaccines|June 27, 2024
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBVCharlotte Davis, Dave Singh, Katie Anderson, et al.
Gastroenterology|May 13, 2019
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirPeter A C Wing, Meleri Jones, Michelle Cheung, et al.
The Lancet Regional Health. Europe|December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyRachael A Evans, Sabada Dube, Yi Lu, et al.
Cell Reports|October 12, 2025
Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine designZhiqing Wang, Isla Humphreys, Jocelyn Quistrebert, et al.
Scientific Reports|May 10, 2019
Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)Anna L McNaughton, Hannah E Roberts, David Bonsall, et al.
The Lancet Regional Health. Europe|August 19, 2024
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747]Rachael A Evans, Sabada Dube, Yi Lu, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceJulia di Iulio, Angela Ciuffi, Karen Fitzmaurice, et al.
Pageof 23